These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27196402)

  • 1. The Comparison of MTT and CVS Assays for the Assessment of Anticancer Agent Interactions.
    Śliwka L; Wiktorska K; Suchocki P; Milczarek M; Mielczarek S; Lubelska K; Cierpiał T; Łyżwa P; Kiełbasiński P; Jaromin A; Flis A; Chilmonczyk Z
    PLoS One; 2016; 11(5):e0155772. PubMed ID: 27196402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay.
    Ulukaya E; Colakogullari M; Wood EJ
    Chemotherapy; 2004 Apr; 50(1):43-50. PubMed ID: 15084806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.
    van Tonder A; Joubert AM; Cromarty AD
    BMC Res Notes; 2015 Feb; 8():47. PubMed ID: 25884200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay.
    Ganot N; Meker S; Reytman L; Tzubery A; Tshuva EY
    J Vis Exp; 2013 Nov; (81):e50767. PubMed ID: 24300943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screen anticancer drug in vitro using resonance light scattering technique.
    Chen Z; Liu G; Chen M; Xu B; Peng Y; Chen M; Wu M
    Talanta; 2009 Feb; 77(4):1365-9. PubMed ID: 19084650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
    Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pyruvic acid analog 3-bromopyruvate interferes with the tetrazolium reagent MTS in the evaluation of cytotoxicity.
    Ganapathy-Kanniappan S; Geschwind JF; Kunjithapatham R; Buijs M; Syed LH; Rao PP; Ota S; Vali M
    Assay Drug Dev Technol; 2010 Apr; 8(2):258-62. PubMed ID: 20085459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
    Kawada K; Yonei T; Ueoka H; Kiura K; Tabata M; Takigawa N; Harada M; Tanimoto M
    Acta Med Okayama; 2002 Jun; 56(3):129-34. PubMed ID: 12108583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
    Plumb JA; Milroy R; Kaye SB
    Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of chemosensitivity tests in vitro for AUC-dependent drugs focusing on the usefulness of MTT assay with drug washout and additional incubation (M-MTT)].
    Takemoto T
    Nihon Ika Daigaku Zasshi; 1993 Jun; 60(3):156-64. PubMed ID: 8331150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
    Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
    J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an in vitro reproductive screening assay for novel pharmaceutical compounds.
    Edwards V; Markovic E; Matisons J; Young F
    Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):63-71. PubMed ID: 18171324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis enzyme-linked immunosorbent assay distinguishes anticancer drugs from toxic chemicals and predicts drug synergism.
    Frankfurt OS; Krishan A
    Chem Biol Interact; 2003 Mar; 145(1):89-99. PubMed ID: 12606157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schönmayr R; Schachenmayr W
    J Neurooncol; 1992 May; 13(1):1-11. PubMed ID: 1613535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MTT and Crystal Violet Assays: Potential Confounders in Nanoparticle Toxicity Testing.
    Almutary A; Sanderson BJ
    Int J Toxicol; 2016 Jul; 35(4):454-62. PubMed ID: 27207930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and genotoxic effects of [Ru(phi)3]2+ evaluated by Ames/Salmonella and MTT methods.
    Benkli K; Tunali Y; Cantürk Z; Artagan O; Alanyali F
    Eur J Med Chem; 2009 Jun; 44(6):2601-5. PubMed ID: 18947906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of MTT by flavonoids in the absence of cells.
    Peng L; Wang B; Ren P
    Colloids Surf B Biointerfaces; 2005 Oct; 45(2):108-11. PubMed ID: 16150580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
    Haselsberger K; Peterson DC; Thomas DG; Darling JL
    Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current methodology of MTT assay in bacteria - A review.
    Grela E; Kozłowska J; Grabowiecka A
    Acta Histochem; 2018 May; 120(4):303-311. PubMed ID: 29606555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of anti-invasive but noncytotoxic chemotherapeutic agents using the tetrazolium dye MTT to quantitate viable cells in Matrigel.
    Sasaki CY; Passaniti A
    Biotechniques; 1998 Jun; 24(6):1038-43. PubMed ID: 9631200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.